Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

NCT05776056 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

70

Enrollment

FED

Sponsor class

Conditions

Posttraumatic Stress Disorder (PTSD)

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

VA Office of Research and Development